1991
DOI: 10.1016/0049-3848(91)90151-l
|View full text |Cite
|
Sign up to set email alerts
|

Effect of 13-hydroxyoctadeca-9,11-dienoic acid (13-hode) on thrombin induced platelet adherence to endothelial cells in vitro

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
15
0

Year Published

1993
1993
2022
2022

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 28 publications
(16 citation statements)
references
References 25 publications
1
15
0
Order By: Relevance
“…This increased binding was evenly distributed over the endothelial cell monolayer. Our results were consistent with data obtained by previously reported methods (3,16,18). 4A).…”
Section: Resultssupporting
confidence: 94%
See 2 more Smart Citations
“…This increased binding was evenly distributed over the endothelial cell monolayer. Our results were consistent with data obtained by previously reported methods (3,16,18). 4A).…”
Section: Resultssupporting
confidence: 94%
“…Existing methods have produced reproducible and useful results with flow cytometry (10,11), radioisotopes (3,4,7,(12)(13)(14)(15)(16)(17), and fluorescence (18) to label platelets. The most significant challenge is in vitro identification and quantification of platelets bound to an intact undisturbed monolayer of endothelial cells.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Additionally, 13-HODE was demonstrated to inhibit thrombin-induced TXB2 and 12-HETE production in platelets as well as platelet adherence to endothelial cells in vitro [99, 100]. Interestingly, 15-HETrE exhibited biphasic effects on platelet aggregation in which low concentrations potentiated and higher concentrations inhibited platelet aggregation [101]. …”
Section: -Lox-derived Metabolites and Regulation Of Platelet Functionmentioning
confidence: 99%
“…These metabolites were shown to have anti-platelet effects mainly through inhibition of collagen and thromboxane-dependent aggregation for 12-HETE [1,2], 13-hydroperoxy-9Z,11E- octadecadienoic acid (13-HPODE) [3] and 13-HODE [4]. This later metabolite was also shown to decrease the adherence of platelets to endothelial cells [5]. The mechanisms by which these anti-platelet molecules affect platelet activation and aggregation involved inhibition of thromboxane (TX) synthesis or blocking of its receptors, ADP, thrombin and collagen receptors as well as blocking of glycoprotein –dependent binding of extracellular matrix and fibrinogen [6,7].…”
Section: Introductionmentioning
confidence: 99%